PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516058
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516058
Molecular Spectroscopy Market - Technology [Nuclear Magnetic Resonance Spectroscopy (Fourier-transform NMR, Solid-state NMR), UV-Visible (Dual-beam UV-visible, Single-beam UV-visible), Infrared, Near-infrared], End-user, Global Forecast (2024 - 2032)
Molecular spectroscopy market size is anticipated to register 6% CAGR between 2024 and 2032, owing to technological advancements and innovations in analytical techniques. Rapid advancements have enabled researchers to conduct more precise analysis in various industries. There is growing demand for molecular imaging in pharmaceutical and biotech sectors for drug development, as well as in quality control across food, beverage, and environmental monitoring. To illustrate, in October 2023, TrinamiX GmbH launched its consumer spectroscopy solution powered by the new Snapdragon(R) 8 Gen 3 reference design.
Surging awareness and acceptance among researchers and the expansion of pharmaceutical and biotech industries in emerging economies is increasing the government financial support for R&D activities. Higher investments in healthcare infrastructure, and the rising demand for molecular spectroscopy instruments from universities and research institutes will also drive the market growth.
The molecular spectroscopy industry is classified into technology, end-user and region.
Based on technology, the market size from the infrared spectroscopy segment will witness significant CAGR through 2032, due to its versatility across various industries. Infrared spectroscopy offers detailed molecular analysis and non-destructive nature, making it crucial in various industries. Advances in technology like handheld devices are also boosting usage in field applications. Growing interest in process analysis technology (PAT) in manufacturing along with increased quality control and assurance will add to the segment growth.
With respect to end-user, the molecular spectroscopy market from the CROs segment is slated to generate notable gains during 2024-2032, due to increasing dependence on advanced analytical techniques for drug discovery and development procedure. CROs offer outsourced research services to pharmaceutical, biotech, and academic institutions by utilizing molecular spectroscopy technology for rapid and accurate diagnostics as well as enhancing research efficiency and reducing turnaround time.
Asia Pacific molecular spectroscopy industry will record sustained growth rate through 2032, attributed to rising pharmaceutical and biotechnology sector. Increased investments in healthcare infrastructure, surge in government initiatives for R&D, and expansion of pharmaceutical manufacturing are boosting the local medicine and biotech sector. Spatial methods are also being used in food & beverage (F&B) sector for quality control, environmental monitoring, and scientific research, further driving the regional market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing application and adoption in pharmaceutical companies
- 3.2.1.2 Rising research and development activities focusing on the creation of novel drugs
- 3.2.1.3 Technological advancement in the field of molecular spectroscopy
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost of molecular spectroscopy
- 3.2.2.2 Requirement of specialized expertise and training
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Nuclear magnetic resonance (NMR) spectroscopy
- 5.2.1 Fourier-transform NMR spectroscopy (FTS)
- 5.2.2 Solid-state NMR spectroscopy (SSNMR)
- 5.2.3 Continuous-wave (CW) NMR spectroscopy
- 5.3 UV-visible spectroscopy
- 5.3.1 Dual-beam UV-visible spectroscopy
- 5.3.2 Single-beam UV-visible spectroscopy
- 5.3.3 Array-based UV-visible spectroscopy
- 5.4 Infrared (IR) spectroscopy
- 5.4.1 Mid-wave infrared spectroscopy
- 5.4.2 Short-wave infrared spectroscopy
- 5.4.3 Far-wave infrared spectroscopy
- 5.5 Near-infrared spectroscopy
- 5.5.1 Fourier-transform
- 5.5.2 Scanning
- 5.5.3 Filter or AOTF
- 5.6 Raman spectroscopy
- 5.6.1 By sampling technique
- 5.6.1.1 Surface-enhanced Raman scattering
- 5.6.1.2 Tip-enhanced Raman scattering
- 5.6.1.3 Other sampling techniques
- 5.6.2 By type
- 5.6.2.1 Micro-raman spectroscopy
- 5.6.2.2 Probe-based raman spectroscopy
- 5.6.2.3 Fourier tranform-raman spectroscopy
- 5.6.1 By sampling technique
- 5.7 Other technologies
Chapter 6 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Pharmaceutical & biotechnology companies
- 6.3 Academic and research institutes
- 6.4 CROs
- 6.5 Other end-users
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
- 7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East and Africa
Chapter 8 Company Profiles
- 8.1 Agilent Technologies Inc.
- 8.2 Bruker Corporation
- 8.3 Danaher Corporation
- 8.4 Horiba Ltd.
- 8.5 Jasco Inc.
- 8.6 Jeol Ltd.
- 8.7 Merck KGaA
- 8.8 PerkinElmer Inc.
- 8.9 Thermo Fisher Scientific Inc.
- 8.10 VIAVI Solutions Inc.
